Dogwood Therapeutics, Inc.: which funds bought and sold
Institutions that bought and sold Dogwood Therapeutics shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 7 institutions that filed 13F reports for both quarters added to or opened positions in Dogwood Therapeutics, and 6 cut or closed them. Together they added a net 209K shares, +5.8% on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 194K shares (+5.9%); index fund managers were net buyers of 37K shares (+12.5%). 5 opened a new position and 3 sold out entirely.
Bought, Q2 2026 7 institutions, 5 of them new holders Sold, Q2 2026 6 institutions, 3 of them sold out
Net change, all compared +209K shares (+5.8%)
Net change, active managers +194K shares (+5.9%), 2 bought, 2 sold
Buyers versus sellers
7 bought 5 6 sold
Active managers and hedge funds 2 bought · 2 sold · +194K
Index fund managers 2 bought · 0 sold · +37K
Other institutions 3 bought · 4 sold · −22K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Millennium Management LLC Hedge fund | +342K New position | 342K | $550,321 |
| Blackrock, Inc. Index funds | +29K +95053.3% | 29K | $45,959 |
| Citadel Advisors LLC Hedge fund | +12K New position | 12K | $18,905 |
| Geode Capital Management, LLC Index funds | +8,864 +11.2% | 88K | $142,161 |
| Morgan Stanley | +2,222 New position | 2,222 | $3,577 |
| Jones Financial Companies LLLP | +160 New position | 160 | $264 |
| Barclays PLC | +157 New position | 157 | $253 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Millennium Management LLC Hedge fund | +342K New position | 342K | $550,321 |
| Citadel Advisors LLC Hedge fund | +12K New position | 12K | $18,905 |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Armistice Capital, LLC Hedge fund | −148K −4.5% | 3.1M | $5M |
| Goldman Sachs Group Inc | −15K Sold out | 0 | — |
| Marshall Wace, LLP Hedge fund | −12K Sold out | 0 | — |
| UBS Group AG | −5,225 −73.7% | 1,860 | $2,995 |
| Tower Research Capital LLC (TRC) | −4,974 −61.7% | 3,093 | $4,980 |
| BNP Paribas Financial Markets | −2 Sold out | 0 | — |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Armistice Capital, LLC Hedge fund | −148K −4.5% | 3.1M | $5M |
| Marshall Wace, LLP Hedge fund | −12K Sold out | 0 | — |
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Millennium Management LLCHedge fund | 342K | $550,321 |
| Citadel Advisors LLCHedge fund | 12K | $18,905 |
| Morgan Stanley | 2,222 | $3,577 |
| Jones Financial Companies LLLP | 160 | $264 |
| Barclays PLC | 157 | $253 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Goldman Sachs Group Inc | 15K | $30,802 |
| Marshall Wace, LLPHedge fund | 12K | $24,805 |
| BNP Paribas Financial Markets | 2 | $4 |
Who holds the shares
- Institutions reporting
- 15
- Ten largest holders
- 99.9% of 13F-reported shares
- Index fund managers
- 8.8% of 13F-reported shares
- Active managers and hedge funds
- 91.0% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 2 | 2 | 2 | 1 | +194K | +5.9% |
| Index fund managers | 2 | 0 | 0 | 0 | +37K | +12.5% |
| Other institutions | 3 | 4 | 3 | 2 | −22K | −74.5% |
← Back to Dogwood Therapeutics, Inc. · Insiders · Politicians